Nexilis AG
  • Home
  • Platforms
    • Immediate Stabilisation System (ISS)
    • Extra Cellular Matrix (ECM) Coating
    • Bisphosponate Coating (BCP)
  • About us
    • Operative Team
    • Member of Clinical & Medical Advisory Board
    • Board of Directors
  • Contact
  • Terms of Use & privacy statement
  • Home
  • Platforms
    • Immediate Stabilisation System (ISS)
    • Extra Cellular Matrix (ECM) Coating
    • Bisphosponate Coating (BCP)
  • About us
    • Operative Team
    • Member of Clinical & Medical Advisory Board
    • Board of Directors
  • Contact
  • Terms of Use & privacy statement

News

Christoph Heinzen: New CEO at Nexilis AG

11/1/2019

0 Comments

 
The Board of Directors has appointed Christoph Heinzen as the new Chief Executive Officer at Nexilis AG. Christoph Heinzen has a strong track record in various positions in the pharmaceutical, BioTech and MedTech Industry with more than 20 years of experience, e.g.  as Chief Operations and Technology Officer at LifeWatch AG, a company dedicated to ECG monitoring services.
Christoph holds an Ph.D. in process engineering (ETHZ) and MBA (BWI NDS ETHZ).

0 Comments



Leave a Reply.

    Archive

    November 2019
    October 2019
    October 2016

    RSS Feed

© 2020 Nexilis AG | Imprint | Disclaimer | Contact